| Pinti Physical Therapy & Sports Medicine | |
|
435 Buckhannon Pike, Nutter Fort, WV 26301-4307 | |
| (304) 622-1600 | |
| (304) 622-4747 |
| Full Name | Pinti Physical Therapy & Sports Medicine |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 435 Buckhannon Pike, Nutter Fort, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477651032 | NPI | - | NPPES |
| 3810000758 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 027587 (West Virginia) | Primary |
| Provider Name | Beth Griffith |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1083930309 PECOS PAC ID: 0446376370 Enrollment ID: I20100928000847 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.
The significant presence of multidrug-resistant gram-negative bacteria, such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
› Verified 1 days ago
| Provider Name | Kelly Pinti |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285627927 PECOS PAC ID: 3274790589 Enrollment ID: I20120127000838 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.
The significant presence of multidrug-resistant gram-negative bacteria, such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
› Verified 1 days ago
| Provider Name | Mark Pinti |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1003800913 PECOS PAC ID: 2567422371 Enrollment ID: I20120324000120 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.
The significant presence of multidrug-resistant gram-negative bacteria, such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pinti Physical Therapy & Sports Medicine 435 Buckhannon Pike, Nutter Fort, WV 26301-4307 Ph: (304) 622-1600 | Pinti Physical Therapy & Sports Medicine 435 Buckhannon Pike, Nutter Fort, WV 26301-4307 Ph: (304) 622-1600 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue their treatment over time.
The significant presence of multidrug-resistant gram-negative bacteria, such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
› Verified 1 days ago
Mr. Mark A Pinti, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 435 Buckhannon Pike, Nutter Fort, WV 26301 Phone: 304-622-1600 Fax: 304-622-4747 | |
Mr. Jerry Blaine Forinash Jr., M.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 611 West Virginia Ave, Nutter Fort, WV 26301 Phone: 304-669-1971 | |
Matthew A Madrid, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2a Cherry Tree Dr, Nutter Fort, WV 26301 Phone: 304-622-5822 Fax: 304-622-9707 | |
Mrs. Beth Ann Griffith, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 435 Buckhannon Pike, Nutter Fort, WV 26301 Phone: 304-622-1600 Fax: 304-622-4747 | |
Mrs. Tracy Lee Garavaglia, M.P.T., A.T.C. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2a Cherry Tree Dr, Nutter Fort, WV 26301 Phone: 304-622-5822 Fax: 304-622-9707 | |
Emily Moore, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 435 Buckhannon Pike, Nutter Fort, WV 26301 Phone: 304-622-1600 Fax: 304-622-4747 |